301 - 350 of 8571 Results
Title
Year
- Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings2017OPENTitle: Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling SettingsJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 26Issue #: 6Start Page: 1165End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0123-6Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10897-017-0123-6Citation Count: 10
- Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients2019RESTRICTEDTitle: Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 410Issue #:Start Page: 116626End Page: 116626Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.116626Citation Count: 20
-
RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107294Citation Count: 0
- Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligase2025OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2025.2531025Citation Count: 0
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 6
-
OPENTitle: Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification AssaysJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1209End Page: 1211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad111Best OA location URL: https://academic.oup.com/clinchem/advance-article-pdf/doi/10.1093/clinchem/hvad111/51472471/hvad111.pdfCitation Count: 1
- Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia2016OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://portal.research.lu.se/files/27488018/5350550_.pdfCitation Count: 24
- Short latency cortical evoked potentials elicited by subthalamic nucleus deep brain stimulation: Commentary and results from paired pulse studies2019RESTRICTEDTitle: Short latency cortical evoked potentials elicited by subthalamic nucleus deep brain stimulation: Commentary and results from paired pulse studiesJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 131Issue #: 2Start Page: 465End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2019.11.015Citation Count: 8
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat2015RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 73
- Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease2012OPENTitle: Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 61Issue #: 1Start Page: 228End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2012.02.066Best OA location URL: http://doi.org/10.1016/j.neuroimage.2012.02.066Citation Count: 71
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 10
-
RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 60
- P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease2013RESTRICTEDTitle: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s diseaseJournal Name: Neuromuscular DisordersPublisher: Elsevier BVVol: 23Issue #: 9-10Start Page: 836End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684Citation Count: 1
-
OPENTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S019745801830383XCitation Count: 16
- Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells2020OPENTitle: Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian CellsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 20Start Page: 3204End Page: 3213Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.0c00300Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00300Citation Count: 6
- It's a double knock‐out! The quaking mouse is a spontaneous deletion of parkin and parkin co‐regulated gene (PACRG)2004RESTRICTEDTitle: It's a double knock‐out! The quaking mouse is a spontaneous deletion of parkin and parkin co‐regulated gene (PACRG)Journal Name: Movement DisordersPublisher: WileyVol: 19Issue #: 1Start Page: 101End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20000Citation Count: 57
-
OPENTitle: Generation of human midbrain organoids from induced pluripotent stem cellsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.12688/mniopenres.12816.1Best OA location URL: https://mniopenresearch.org/articles/3-1/v1/pdfCitation Count: 12
- Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis Genes2023OPENTitle: Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis GenesJournal Name: Human MutationPublisher: WileyVol: 2023Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/8620557Best OA location URL: https://downloads.hindawi.com/journals/humu/2023/8620557.pdfCitation Count: 0
- Prevalence of heterozygous mutations in Niemann-Pick type C genes in a cohort of progressive supranuclear palsy2020RESTRICTEDTitle: Prevalence of heterozygous mutations in Niemann-Pick type C genes in a cohort of progressive supranuclear palsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 9End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.013Citation Count: 4
-
OPENTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Best OA location URL: https://europepmc.org/articles/pmc3110693?pdf=renderCitation Count: 7
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure2021OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic FailureJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 6Start Page: 1212End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8168720Citation Count: 77
- Freesurfer cortical normative data for adults using Desikan-Killiany-Tourville and ex vivo protocols2017OPENTitle: Freesurfer cortical normative data for adults using Desikan-Killiany-Tourville and ex vivo protocolsJournal Name: NeuroImagePublisher: Elsevier BVVol: 156Issue #:Start Page: 43End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.04.035Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811917303269?via%3DihubCitation Count: 45
-
OPENTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 23
-
OPENTitle: Lack of evidence for genetic association of saposins A, B, C and D with Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 9Start Page: e72End Page: e72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa214Best OA location URL: https://academic.oup.com/brain/article-pdf/143/9/e72/34280049/awaa214.pdfCitation Count: 13
-
OPENTitle: First-in-human PET neuroimaging of [18F]OXD-2314Journal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1007/s00259-025-07413-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-025-07413-w.pdfCitation Count: 0
- DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study2020RESTRICTEDTitle: DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 36End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.019Citation Count: 8
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice2015OPENTitle: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 172End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031Best OA location URL: http://doi.org/10.1016/j.nbd.2015.02.031Citation Count: 246
- A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging2017OPENTitle: A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 69End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.12.050Citation Count: 102
- A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients2011RESTRICTEDTitle: A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 310Issue #: 1-2Start Page: 248End Page: 250Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.021Citation Count: 38
- Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons2014OPENTitle: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 69Issue #:Start Page: 263End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4135465Citation Count: 31
- How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology2020OPENTitle: How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105086End Page: 105086Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105086Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105086Citation Count: 129
- Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export2020OPENTitle: Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide exportJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 139Issue #: 6Start Page: 1001End Page: 1024Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-020-02145-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-020-02145-7.pdfCitation Count: 58
- Somatosensory-motor cortex interactions measured using dual-site transcranial magnetic stimulation2019RESTRICTEDTitle: Somatosensory-motor cortex interactions measured using dual-site transcranial magnetic stimulationJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 1229End Page: 1243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.04.009Citation Count: 17
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978749Citation Count: 64
- Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A2017OPENTitle: Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 25Start Page: 10328End Page: 10346Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.764076Best OA location URL: https://doi.org/10.1074/jbc.m116.764076Citation Count: 81
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Best OA location URL: https://www.nature.com/articles/s41467-024-51889-3.pdfCitation Count: 9
- Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD2022OPENTitle: Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PDJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 333End Page: 338Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29284Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29284Citation Count: 21
- Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity2018OPENTitle: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27392Best OA location URL: https://europepmc.org/articles/pmc6146055?pdf=renderCitation Count: 139
- Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel2024OPENTitle: Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogelJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 21Issue #: 2Start Page: 024002End Page: 024002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1741-2552/ad33b2Best OA location URL: https://iopscience.iop.org/article/10.1088/1741-2552/ad33b2/pdfCitation Count: 7
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease2018OPENTitle: Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 2Start Page: 279End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-018-1948-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-018-1948-2.pdfCitation Count: 144
-
RESTRICTEDTitle: Essential tremor and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 125End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012Citation Count: 3
-
OPENTitle: A Novel PINK1 p.F385S Loss‐of‐Function Mutation in an Indian Family with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 7Start Page: 1217End Page: 1225Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29792Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29792Citation Count: 1
- Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity2019OPENTitle: Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and CytotoxicityJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-54063-8Best OA location URL: https://www.nature.com/articles/s41598-019-54063-8.pdfCitation Count: 23
- Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score2016OPENTitle: Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreJournal Name: European Journal of NeurosciencePublisher: WileyVol: 45Issue #: 1Start Page: 175End Page: 191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.13476Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13476Citation Count: 24
- Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body disease2020OPENTitle: Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/braincomms/fcaa004Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcaa004/33639616/fcaa004.pdfCitation Count: 10
- The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons2024OPENTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Best OA location URL: https://www.nature.com/articles/s41467-024-49256-3.pdfCitation Count: 7
-
OPENTitle: Foundations of circadian medicineJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 3Start Page: e3001567End Page: e3001567Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001567Best OA location URL: https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001567&type=printableCitation Count: 73
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914.3Best OA location URL: https://cdn.elifesciences.org/articles/99914/elife-99914-v1.pdfCitation Count: 0
- Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM202020OPENTitle: Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00139-6Best OA location URL: https://www.nature.com/articles/s41531-020-00139-6.pdfCitation Count: 29